RT Journal Article
SR Electronic
T1 Spot the Difference: Can ChatGPT4-Vision Transform Radiology Artificial Intelligence?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.15.23298499
DO 10.1101/2023.11.15.23298499
A1 Kelly, Brendan S
A1 Duignan, Sophie
A1 Mathur, Prateek
A1 Dillon, Henry
A1 Lee, Edward H
A1 Yeom, Kristen W
A1 Keane, Pearse
A1 Lawlor, Aonghus
A1 Killeen, Ronan P
YR 2023
UL http://medrxiv.org/content/early/2023/11/18/2023.11.15.23298499.abstract
AB OpenAI’s flagship Large Language Model ChatGPT can now accept image input (GPT4V). “Spot the Difference” and “Medical” have been suggested as emerging applications. The interpretation of medical images is a dynamic process not a static task. Diagnosis and treatment of Multiple Sclerosis is dependent on identification of radiologic change. We aimed to compare the zero-shot performance of GPT4V to a trained U-Net and Vision Transformer (ViT) for the identification of progression of MS on MRI.170 patients were included. 100 unseen paired images were randomly used for testing. Both U-Net and ViT had 94% accuracy while GPT4V had 85%. GPT4V gave overly cautious non-answers in 6 cases. GPT4V had a precision, recall and F1 score of 0.896, 0.915, 0.905 compared to 1.0, 0.88 and 0.936 for U-Net and 0.94, 0.94, 0.94 for ViT.The impressive performance compared to trained models and a no-code drag and drop interface suggest GPT4V has the potential to disrupt AI radiology research. However misclassified cases, hallucinations and overly cautious non-answers confirm that it is not ready for clinical use. GPT4V’s widespread availability and relatively high error rate highlight the need for caution and education for lay-users, especially those with limited access to expert healthcare.Key pointsEven without fine tuning and without the need for prior coding experience or additional hardware, GPT4V can perform a zero-shot radiologic change detection task with reasonable accuracy.We find GPT4V does not match the performance of established state of the art computer vision models. GPT4V’s performance metrics are more similar to the vision transformers than the convolutional neural networks, giving some possible insight into its underlying architecture.This is an exploratory experimental study and GPT4V is not intended for use as a medical device.Summary statement GPT4V can identify radiologic progression of Multiple Sclerosis in a simplified experimental setting. However GPT4V is not a medical device and its widespread availability and relatively high error rate highlight the need for caution and education for lay-users, especially those with limited access to expert healthcare.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was performed within the Irish Clinical Academic Training (ICAT) Programme, supported by the Wellcome Trust and the Health Research Board (Grant No. 203930/B/16/Z), the Health Service Executive National Doctors Training and Planning and the Health and Social Care, Research and Development Division, Northern Ireland and the Faculty of Radiologists, Royal College of Surgeons in Ireland. This research was supported by Science Foundation Ireland (SFI) under Grant Number SFI/12/RC/2289_P2 and by a Fulbright-HRB HealthImpact Scholarship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of St Vincent's University hospital gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors (CNS)Central Nervous System(GPT4V)Chat Generative Pretrained Transformer 4 Vision(MRI)Magnetic Resonance Imaging(MS)Vision Transformers(ViT)Multiple sclerosis